FDA Adverse Event Injury Summary report: N

ASR ACETABULAR CUPS 46

MDR report key: 2831978 · Received November 14, 2012

Report

Report Number
1818910-2012-24889
Event Type
Injury
Date Received
November 14, 2012
Report Date
October 22, 2012
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z# = Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

ADDITIONAL NARRATIVE: (B)(4). THE INVESTIGATION HAS BEEN REOPENED DUE TO RECEIVING REVISION DATE. DEPUY WILL NOTIFY THE FDA WHEN THE INVESTIGATION IS COMPLETE.

Additional Manufacturer Narrative · 1

ADDITIONAL NARRATIVE: THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

LITIGATION ALLEGES PATIENT HAD PAIN AND DISCOMFORT WHICH AFFECTS ABILITY TO WALK, SLEEP AND MOVE; AND ELEVATED METAL LEVELS IN BLOOD AFTER ASR HIP IMPLANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASR ACETABULAR CUPS 46 HIP ACETABULAR CUP KWA DEPUY INTERNATIONAL 2738948

Patients

Seq Age Sex Outcome Treatment
1 Other